Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies (2022)
- Authors:
- USP affiliated authors: ANDRICOPULO, RENATA KROGH - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC ; VALLI, MARILIA - IFSC ; FERREIRA, LEONARDO LUIZ GOMES - IFSC ; SOUZA, JULIA MEDEIROS - IFSC
- Unidade: IFSC
- DOI: 10.4155/fmc-2022-0013
- Subjects: FÁRMACOS; PLANEJAMENTO DE FÁRMACOS; DOENÇAS PARASITÁRIAS; DOENÇA DE CHAGAS
- Keywords: Chagas disease; QSAR; Chalcones; Cruzain; Molecular docking
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 14, n. 11, p. 795-808, June 2022
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
OLIVEIRA, Aldo Sena de et al. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, v. 14, n. 11, p. 795-808, 2022Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0013. Acesso em: 01 abr. 2026. -
APA
Oliveira, A. S. de, Valli, M., Ferreira, L. L. G., Souza, J. M., Krogh, R., Meier, L., et al. (2022). Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, 14( 11), 795-808. doi:10.4155/fmc-2022-0013 -
NLM
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Krogh R, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4155/fmc-2022-0013 -
Vancouver
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Krogh R, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2026 abr. 01 ] Available from: https://doi.org/10.4155/fmc-2022-0013 - Natural products for drug discovery: cytochalasins with antitrypanosomal activity
- Synthesis of 1,2,3-triazole selenides with anti-T. cruzi activity
- Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids
- DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease
- Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-trypanosoma cruzi activity
- Synthesis and anti-trypanosoma cruzi activity of 3-cyanopyridine derivatives
- Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids
- Identification of natural cytochalasins as leads for neglected tropical diseases drug discovery
- Structure-metabolism relationships of benzimidazole derivatives with anti-Trypanosoma cruzi activity for Chagas disease
- Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
